HCV SAVINE (Savine)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHCV SAVINE (Savine)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSavine Therapeutics Pty Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSavine Therapeutics Pty Ltd

Active IndicationsN/A

Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A